DUBLIN--(BUSINESS WIRE)--The "Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The global stem cell banking market was worth US$ 8.1 Billion in 2018. Looking forward, we expect the global stem cell banking market to reach a value of US$ 17.3 Billion by 2024, exhibiting a CAGR of 13.5% during 2019-2024.
While the average human life expectancy has increased owing to the advancements in medical science, human aging is still associated with several diseases. Thus, the elevating count of geriatric population will drive the demand for stem cell therapy in the coming years.
Regulatory authorities as well as non-governmental organizations (NGO), across both developed and emerging regions, are taking initiatives for instilling awareness amongst consumers about the therapeutic potentials of stem cells, thereby influencing the stem cell banking market growth.
Increasing fertility rates has led to a rise in the number of children across the globe. This offers lucrative opportunities for preserving the umbilical cord of infants which contains hematopoietic (blood) stem cells.
Some of the other factors which are catalyzing the growth of the market include escalating disposable incomes, increasing approval of clinical trials in stem cell research, growing prevalence of chronic diseases and technological advancements.
Product Type Insights
On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.
Service Type Insights
Based on service types, the market has been segmented as sample preservation and storage; sample analysis; sample processing; and sample collection and transportation.
Bank Type Insights
Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.
Utilization Insights
Based on the utilization, the market has been segregated as used and unused.
Application Insights
On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.
Regional Insights
On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape
The market is fragmented in nature with the presence various international as well as regional players. Some of the leading players operating in the market are:
- CBR Systems Inc.
- China Cord Blood Corporation
- Cordlife
- Cordvida
- Cryo-Cell International Inc.
- Cryo-Save AG (A Group of Esperite)
- Cryoviva India
- Lifecell
- Smart Cells International Ltd.
- Viacord
Key Questions Answered
- How has the global stem cell banking market performed so far and how will it perform in the coming years?
- What are the key regions in the global stem cell banking market?
- What is the breakup of the global stem cell banking market on the basis of product type?
- What is the breakup of the global stem cell banking market on the basis of service type?
- What is the breakup of the global stem cell banking market on the basis of bank type?
- What is the breakup of the global stem cell banking market on the basis of utilization?
- What is the breakup of the global stem cell banking market on the basis of application?
- What are the various stages in the value chain of the global stem cell banking market?
- What are the key driving factors and challenges in the global stem cell banking market?
- What is the structure of the global stem cell banking market and who are the key players?
- What is the degree of competition in the global stem cell banking market?
Topics Covered
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Properties
4.3 Key Industry Trends
5 Global Stem Cell Banking Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product Type
5.4 Market Breakup by Service Type
5.5 Market Breakup by Bank Type
5.6 Market Breakup by Utilization
5.7 Market Breakup by Application
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Product Type
6.1 Adult Stem Cells
6.2 Human Embryonic Cells
6.3 IPS Cells
7 Market Breakup by Service Type
7.1 Sample Preservation and Storage
7.2 Sample Analysis
7.3 Sample Processing
7.4 Sample Collection and Transportation
8 Market Breakup by Bank Type
8.1 Private
8.2 Public
9 Market Breakup by Utilization
9.1 Used
9.2 Unused
10 Market Breakup by Application
10.1 Personalized Banking Applications
10.2 Research Applications
10.3 Clinical Applications
11 Market Breakup by Region
11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 Middle East and Africa
11.5 Latin America
12 Global Stem Cell Banking Industry: SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Global Stem Cell Banking Industry: Value Chain Analysis
14 Global Stem Cell Banking Industry: Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Global Stem Cell Banking Industry: Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 CBR Systems Inc.
16.3.2 China Cord Blood Corporation
16.3.3 Cordlife
16.3.4 Cordvida
16.3.5 Cryo-Cell
16.3.6 Cryo-Save AG (A Group of Esperite)
16.3.7 Cryoviva India
16.3.8 Lifecell
16.3.9 Smart Cells International Ltd.
16.3.10 Viacord
For more information about this report visit https://www.researchandmarkets.com/research/s58dzl/the_global_market?w=4
